Together, these findings indicate that CD8 T cells increase in cellularity and at least partially infiltrate the tumors after immunotherapy, as well as that the TCF1+PD1+ progenitor and TCF1-PD1+ effector CD8 T cells have non-equivalent spatial distribution properties within the tumor tissues. Here, CD8A is linked to neoplasm.